HomeStock ScreenerEmmessar BiotechQuarterly Results

Emmessar Biotech Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹0 Cr
QMarch 2025
Quarterly Results

In March 2026, Emmessar Biotech (EMMESSA) reported revenue ₹0 Cr and net profit ₹0 Cr. For annual financials, live price and key ratios, visit Emmessar Biotech stock price NSE.

EMMESSA Quarterly Results — Revenue, Profit & EPS Highlights

Emmessar Biotech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with Emmessar Biotech valuation methods to assess whether the stock is under or overvalued.

  • Revenue of ₹3 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
  • EBITDA of ₹1 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of -156.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹0.63 in March 2025 (+0.0% vs March 2025)

Emmessar Biotech Quarterly Results — Revenue, EBITDA, Net Profit & EPS

EMMESSA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric March 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 0 3 3 3 2 - -
Net Profit (₹ Cr) 0 0 1 1 1 - -
EBITDA (₹ Cr) -1 1 1 1 1 - -
EPS (₹) 0.81 0.63 1.50 0.99 0.94 - -
Operating Margin (%) -365.0% -156.0% -195.0% -68.0% -245.0% - -

EMMESSA Share Price Trend — 1-Year Movement Across Quarterly Results

Emmessar Biotech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore EMMESSA price movement history to track price trends across different timeframes.

Profitability Ratios

EBITDA Margin 33.3%
Operating Margin -156.0%

Balance Sheet Highlights

Total Assets ₹10 Cr
Total Equity ₹8 Cr
Current Assets ₹8 Cr
Current Liabilities ₹1 Cr

Cash Flow Analysis

Operating Cash Flow ₹0 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹0 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹25.93
Exchange BSE
Last Updated May 27, 2026

EMMESSA vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap

Emmessar Biotech latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Pidilite Industries
Mar 2026
₹150,700.65 Cr 1480.7 3,648 584 +1.2% +13.2% 16.0% 260.2
SRF
Mar 2026
₹81,125.55 Cr 2736.8 4,557 582 +28.0% +7.2% 12.8% 139.4
Linde
Sept 2025
₹61,592.27 Cr 7259.0 650 171 +7.4% - 26.3% 362.0
Fertilisers & Chemi…
Sept 2025
₹58,928.84 Cr 923.4 1,681 21 +48.8% - 1.2% 2885.6
UPL
Mar 2026
₹55,390.17 Cr 656.2 18,513 1,294 +49.2% +18.1% 7.0% 52.2
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores